Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment
| | | | | | |

Trichuriasis in Human Patients from Côte d’Ivoire Caused by Novel Species resistant to Albendazole/Ivermectin Combination Treatment

On Dec. 18, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported a study with patient…

Tonix Pharma announced a research collaboration and exclusive agreement with the University of Alberta to develop novel c-based vaccines for prevention of COVID-19
| |

Tonix Pharma announced a research collaboration and exclusive agreement with the University of Alberta to develop novel c-based vaccines for prevention of COVID-19

On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…